CRYO SAVE GROUP : -Save Group N.V.: New storage record
01/10/2012| 01:05am US/Eastern
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, stored 39,900 new samples in 2011, up 4% (2010: 38,300 new samples).
· 10,300 new samples stored in Q4 2011, up 3% compared to previous quarter (Q3 2011:10,000). Of these, 6,400 were new cord blood samples and 3,900 new cord tissue samples. 10,400 new samples were stored in Q4 2010.
· 39,900 new samples stored in 2011, up 4% compared to previous year (2010:38,300). Of these, 25,200 were new cord blood samples and 14,700 new cord tissue samples.
· 204,000 samples have been stored in total at 31 December 2011.
· The cash balance increased to approximately ?7 million at 31 December 2011.
Arnoud van Tulder, Chief Executive officer, commented:
"We are pleased to report a new company record of almost 40,000 new samples stored in a year, and crushing the landmark of having more than 200,000 samples stored in our ultramodern state-of the art processing and storage facilities.
"We are confident that our growth strategy will result in continued increasing storage volumes in 2012".
| Cryo-Save Group|| + 31 (0) 575 548 998|
| Arnoud van Tulder, Chief Executive Officer || |
| || |
| SPJ Financiėle Communicatie (The Netherlands)|| +31 (0)20 647 8181|
| Kees Jongsma/Leon Melens|| |
| Daniel Stewart & Company plc (UK)|| + 44 (0) 20 7776 6550|
| Sean Lunn|| |
| || |
| College Hill (UK)|| + 44 (0) 20 7457 2020|
| Rozi Morris/ Adrian Duffield|| |
Free footage is available on www.videobankonline.com:
About Cryo-Save (www.cryo-save.com/group:
Cryo-Save, the leading international family stem cell bank, already stores more than 204,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Click here for press release in PDF:
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE